Andrew McLarnon

571 total citations
8 papers, 469 citations indexed

About

Andrew McLarnon is a scholar working on Immunology, Epidemiology and Hematology. According to data from OpenAlex, Andrew McLarnon has authored 8 papers receiving a total of 469 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Immunology, 2 papers in Epidemiology and 2 papers in Hematology. Recurrent topics in Andrew McLarnon's work include Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (4 papers). Andrew McLarnon is often cited by papers focused on Immune Cell Function and Interaction (6 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (4 papers). Andrew McLarnon collaborates with scholars based in United Kingdom and Hong Kong. Andrew McLarnon's co-authors include Paul Moss, Naeem Khan, Karen Piper Hanley, Nikaïa Smith, Laxman Nayak, Wenbin Wei, Julie Arrazi, Mark Cook, Guy Pratt and Claire Horlock and has published in prestigious journals such as Blood, American Journal Of Pathology and Biology of Reproduction.

In The Last Decade

Andrew McLarnon

8 papers receiving 465 citations

Peers

Andrew McLarnon

IMMUN

EPIDE

ONCOL

HEMAT

MB

Julie Arrazi United Kingdom

Nassima Fodil-Cornu Canada

Henk E. Viëtor Netherlands

Janet K. Seeley United States

Gertjan Lugthart Netherlands

Hironari Niiya Japan

Pavankumar Reddy Varanasi Germany

Louise J. Lathbury Australia

H E Heslop United States

Bérengère de Laval France

Julie Arrazi United Kingdom

Andrew McLarnon

170 ×0.6

IMMUN

76 ×0.3

EPIDE

67 ×0.7

ONCOL

180 ×2.8

HEMAT

46 ×0.8

MB

Citations per year, relative to Andrew McLarnon Andrew McLarnon (= 1×) peers Julie Arrazi

Countries citing papers authored by Andrew McLarnon

Since Specialization

Citations

This map shows the geographic impact of Andrew McLarnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew McLarnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew McLarnon more than expected).

Fields of papers citing papers by Andrew McLarnon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew McLarnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew McLarnon. The network helps show where Andrew McLarnon may publish in the future.

Co-authorship network of co-authors of Andrew McLarnon

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew McLarnon. A scholar is included among the top collaborators of Andrew McLarnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew McLarnon. Andrew McLarnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Parsonage, Greg, Lee R. Machado, Andrew McLarnon, et al.. (2012). CXCR6 and CCR5 Localize T Lymphocyte Subsets in Nasopharyngeal Carcinoma. American Journal Of Pathology. 180(3). 1215–1222. 36 indexed citations

2.

Hanley, Karen Piper, Andrew McLarnon, Emma Kalk, et al.. (2011). Chronic lymphocytic leukaemia cells drive the global CD4+ T cell repertoire towards a regulatory phenotype and leads to the accumulation of CD4+ forkhead box P3+ T cells. Clinical & Experimental Immunology. 166(2). 154–163. 43 indexed citations

3.

McLarnon, Andrew, Karen Piper Hanley, Oliver Goodyear, et al.. (2010). CD8+ T-cell immunity against cancer-testis antigens develops following allogeneic stem cell transplantation and reveals a potential mechanism for the graft-versus-leukemia effect. Haematologica. 95(9). 1572–1578. 14 indexed citations

4.

Khan, Naeem, Wenbin Wei, Andrew McLarnon, et al.. (2009). Cytomegalovirus-seropositivity has a profound influence on the magnitude of major lymphoid subsets within healthy individuals. Clinical & Experimental Immunology. 155(3). 423–432. 199 indexed citations

5.

Goodyear, Oliver, Guy Pratt, Andrew McLarnon, et al.. (2008). Differential pattern of CD4+ and CD8+ T-cell immunity to MAGE-A1/A2/A3 in patients with monoclonal gammopathy of undetermined significance (MGUS) and multiple myeloma. Blood. 112(8). 3362–3372. 32 indexed citations

6.

Pourgheysari, Batoul, Karen Piper Hanley, Andrew McLarnon, et al.. (2008). Early reconstitution of effector memory CD4+ CMV-specific T cells protects against CMV reactivation following allogeneic SCT. Bone Marrow Transplantation. 43(11). 853–861. 69 indexed citations

7.

Stanković, Tatjana, Andrew McLarnon, Angelo Agathanggelou, et al.. (2008). Epigenetic Manipulation of Cancer Testis Antigen (CTA) Expression: A Strategy for Manipulating the Graft-Versus Leukaemia Response in Patients Allografted for Haematological Malignancies. Blood. 112(11). 600–600. 5 indexed citations

8.

Hanley, Karen Piper, Andrew McLarnon, Julie Arrazi, et al.. (2006). Functional HY-Specific CD8+ T Cells Are Found in a High Proportion of Women Following Pregnancy with a Male Fetus1. Biology of Reproduction. 76(1). 96–101. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact